CytoDyn Appoints Seenu Srinivasan as Executive Director of CMC Regulatory Affairs
CytoDyn Inc. (OTCQB: CYDY) ("CytoDyn" or the "Company") announced today the appointment of Seenu Srinivasan, Ph.D., as Executive Director-CMC Regulatory Affairs.
August 27, 2021
by firstwordpharma
Frontage Opens New Lab Facility in Exton, PA
Frontage Laboratories, Inc. completed construction of a new 71,000 sq.-ft. laboratory facility in Exton, PA.
August 10, 2021
by contractpharma
ImmVira Launches Pilot-scale Production Line to Expedite the Advancement of Next-generation OV Clinical Trials
On July 18, 2021, ImmVira inaugurated a pilot-scale production line in Shenzhen and officially initiated its in-house production of our next-generation oncolytic viruses (OV) used for IND applications and Phase I/II clinical trials.
July 19, 2021
by prnasia
CatSci Opens New Dagenham Laboratory
New facility is equipped with state-of-the-art analytical equipment through a collaboration with Shimadzu Corporation.
June 10, 2021
by contractpharma
LINK Medical Expands its Regulatory Services Team, Strengthening its IMPD & CMC Capabilities
LINK Medical expands its regulatory services team, strengthening its IMPD & CMC capabilities.
May 6, 2021
by PharmaSources
TCG Lifesciences Expands Footprint to the U.S.
TCG Lifesciences Pvt. Ltd., a company controlled by New York-based The Chatterjee Group, has expanded its operations in the U.S. with the establishment of TCG GreenChem Inc., a subsidiary of TCG Lifesciences to provide contract development and ...
February 9, 2021
by contractpharma
Passage Bio Invests in Gene Therapy Manufacturing R&D Site
In combination with dedicated cGMP suite at Catalent, the new lab creates foundation for integrated AAV gene therapy manufacturing.
December 18, 2020
by contractpharma
Parexel Launches COVID-19 Risk Mitigation Offering
Four-step methodology aims ensure manufacturers can safely continue manufacturing operations through the COVID-19 pandemic.
May 14, 2020
by contractpharma
CMC Pharmaceuticals Launches cGMP Lab Services
Addition includes the upgrading of laboratory SOPs and documentation practices to comply with U.S. FDA guidelines.
September 18, 2019
by contractpharma
Great Bay Bio Adds Two Industry leaders to Advisory board
he board of directors eagerly welcome two top industry elites, Dr Katie Su and Mr Aaron Wang, to the company with the establishment of its 3D Advisory Board
August 15, 2019
by biospectrumasia
CDMO Great Bay Bio Founded
To build platform for CMC technology and pre-clinical R&D; names Michael Chan as CEO.
June 19, 2019
by contractpharma
China puts focus on tackling biomedical problems
Collaborating with CMC and China National Center for Biotechnology Development (CNCBD), ICGEB decided to set up the world’s first ICGEB regional research center (ICGEB-RRC) at CMC.
April 29, 2019
by biospectrumasia